Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.51 USD | -0.05% | -15.20% | -10.85% |
May. 30 | Bruker Prices Offering of 6 Million Shares | MT |
May. 29 | Bruker Shares Fall Following Public Offering of 6 Million Shares | MT |
Financials (USD)
Sales 2024 * | 3.38B | Sales 2025 * | 3.62B | Capitalization | 9.91B |
---|---|---|---|---|---|
Net income 2024 * | 310M | Net income 2025 * | 420M | EV / Sales 2024 * | 3.2 x |
Net Debt 2024 * | 900M | Net Debt 2025 * | 554M | EV / Sales 2025 * | 2.89 x |
P/E ratio 2024 * |
30.9
x | P/E ratio 2025 * |
22.1
x | Employees | 9,707 |
Yield 2024 * |
0.31% | Yield 2025 * |
0.3% | Free-Float | 55.15% |
Latest transcript on Bruker Corporation
1 day | -0.05% | ||
1 week | -15.20% | ||
1 month | -6.53% | ||
3 months | -25.83% | ||
6 months | -0.83% | ||
Current year | -10.85% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Laukien
CEO | Chief Executive Officer | 64 | 91-01-31 |
Gerald Herman
DFI | Director of Finance/CFO | 66 | 16-11-30 |
Thorsten Thiel
IRO | Public Communications Contact | - | 10-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Ornell
BRD | Director/Board Member | 66 | 15-08-18 |
William Linton
BRD | Director/Board Member | 77 | 00-01-31 |
Robert Rosenthal
BRD | Director/Board Member | 67 | 15-11-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.16% | 85 M€ | -0.54% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 65.51 | -0.05% | 2,020,886 |
24-05-30 | 65.54 | -9.66% | 5,985,818 |
24-05-29 | 72.55 | -4.36% | 767,762 |
24-05-28 | 75.86 | -1.80% | 556,346 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.85% | 9.91B | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- BRKR Stock